After Legalization Recreational Cannabis in Connecticut Marijuana Sales Continue To Rise!
Customers have flocked to Connecticut dispensaries since recreational marijuana sales began there a month ago. Many dispensaries in the state reported increased business over the past month, with one reporting a tripling in customer volume. To represent Zen Leaf in his territory Gary Krol, regional director.
To meet customer needs, he said, the Meriden branch had to hire 25 more workers. Krol noted that where they once saw 200 or 300 patients per day, they now see close to 1,000 patients each day. In Newington, at Fine Fettle, they’ve made some changes as well.
According to pharmacist Ludwig Rosiclair, Fine Fettle in Newington has expanded its staff to accommodate both walk-in customers and those who don’t bother to place an order in advance. Rosiclair explained, “We’ve altered our workflow, we’ve added more staff.
We’re better trained now so that when people who just want to be able to walk in and maybe talk to someone for a couple of minutes, figure out what they want to get and get an order relatively quickly; we have accommodated that.”
Even though these dispensaries refused to discuss their revenue, the most recent numbers from the Connecticut Department of Consumer Protection show that the state made over $13 million in cannabis sales between January 10 and 31.
This includes over $5 million in recreational sales and over $8 million in medical sales. Recreational and medical marijuana sales in Connecticut hit $13.3 million in January. People have shown the most interest in purchasing flowers, vaporizers, and consumables.
Shopkeepers report no dearth of merchandise and are continually replenishing their shelves. We order several times a week, but our inventory turns over very rapidly. From all four of the producers, we receive many deliveries per week,” Krol remarked.
In an interview, Zen Leaf‘s owner admitted that she had seen some price hikes for people who needed medical marijuana. According to what Krol has heard, manufacturers have raised prices, and those hikes have been passed on to patients. Rosiclair remarked, “We don’t have, necessarily, a shortage of products,” but patients “would like to see a greater variety” of options.